Takis is a biotech dedicated to cancer research. Our primary objective is the development of innovative therapies based on the principle that our immune system can be “instructed” to recognize the tumor and reject it as a foreign entity. For this purpose, Takis offers cutting-edge technologies and works with the idea that new cancer treatment must be based on in-depth knowledge of tumour biology and the concept of personalized cancer therapy. Together with some of its partners, Takis is involved in the identification of new biomarkers and in the development of molecular diagnostic tests.
The main competence of Takis’ researchers is the delivery of genes in vivo through numerous technologies. The foremost one is the electric transfer of genes (gene-electro-transfer–EGT) on which we have more than ten years experience. This technology can significantly increase the tissue uptake of nucleic acids in vivo, such as skeletal muscle, or the tumor itself, with a functional enhancement that leads to relevant immunological and antitumoral effects. In this regard,
In addition to its research pipeline, Takis is engaged with academic and industrial partners in research aimed at studying the effectiveness of innovative drugs in biological systems or develop diagnostic tests based on the detection of new biomarkers. Takis offers itself as partner of choice because of its efficiency, speed of execution and low operating costs.
Company Details
- Employees
- 63
- Founded
- -
- Address
- Rome
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- takis-it.it
- Keywords
- Cancer Research, Cancer Biomarkers, Cancer Vaccines, Immunologic Assays, Therapeutic Monoclonal Antibodies, Drug Testing - Proliferation Assays, Optimized Gene Expression Vectors, immunotherapy.
- HQ
- Rome
Takis Questions
Takis's website is takis-it.it
Takis's LinkedIn profile is https://it.linkedin.com/company/takis
Takis has
63 employees.
View email and phone details for 63
employees at Takis.
Takis's industry is
Biotechnology Research
Takis's top competitors are
Alfasigma,
Biorep,
Generon S.p.a.,
Vivabiocell,
Nouscom,
Reithera,
Angelini Pharma,
Biogem Istituto Di Biologia E Genetica Molecolare,
Irbm,
Bsp Pharmaceuticals S.p.a..
Takis's categories are Biotechnology Research
Takis's founding year is 2009
